Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Sizemore

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|June 29, 2019
Editorial: NTM-The New Uber-BugsVeronique Dartois, Christine Sizemore, Thomas Dick
Antimicrobial Agents and Chemotherapy|January 30, 2016
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug DevelopmentEric Nuermberger, Christine Sizemore, Klaus Romero, et al.
The Journal of Infectious Diseases|March 27, 2012
Viewpoint: Challenges and opportunities in tuberculosis researchPeter S Kim, Mamodikoe Makhene, Christine Sizemore, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Plos Neglected Tropical Diseases|May 31, 2014
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical studyBecky L Rivoire, Nathan A Groathouse, Stephen TerLouw, et al.
The Journal of Infectious Diseases|April 6, 2012
Clinical research and development of tuberculosis diagnostics: moving from silos to synergyPayam Nahid, Peter S Kim, Carlton A Evans, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|June 29, 2019
Editorial: NTM-The New Uber-BugsVeronique Dartois, Christine Sizemore, Thomas Dick
Antimicrobial Agents and Chemotherapy|January 30, 2016
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug DevelopmentEric Nuermberger, Christine Sizemore, Klaus Romero, et al.
The Journal of Infectious Diseases|March 27, 2012
Viewpoint: Challenges and opportunities in tuberculosis researchPeter S Kim, Mamodikoe Makhene, Christine Sizemore, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Plos Neglected Tropical Diseases|May 31, 2014
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical studyBecky L Rivoire, Nathan A Groathouse, Stephen TerLouw, et al.
The Journal of Infectious Diseases|April 6, 2012
Clinical research and development of tuberculosis diagnostics: moving from silos to synergyPayam Nahid, Peter S Kim, Carlton A Evans, et al.
Pageof 1